phosphoserine has been researched along with Granulocytic Leukemia, Chronic in 2 studies
Phosphoserine: The phosphoric acid ester of serine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, SY | 1 |
| Liu, YH | 1 |
| Chen, YJ | 1 |
| Yeh, YY | 1 |
| Huang, HM | 1 |
| Bernusso, VA | 1 |
| Machado-Neto, JA | 1 |
| Pericole, FV | 1 |
| Vieira, KP | 1 |
| Duarte, AS | 1 |
| Traina, F | 1 |
| Hansen, MD | 1 |
| Olalla Saad, ST | 1 |
| Barcellos, KS | 1 |
2 other studies available for phosphoserine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
CD69 partially inhibits apoptosis and erythroid differentiation via CD24, and their knockdown increase imatinib sensitivity in BCR-ABL-positive cells.
Topics: Antigens, CD; Antigens, CD34; Antigens, Differentiation, T-Lymphocyte; Apoptosis; CD24 Antigen; Cell | 2018 |
Imatinib restores VASP activity and its interaction with Zyxin in BCR-ABL leukemic cells.
Topics: Apoptosis; bcl-X Protein; Benzamides; Bone Marrow Cells; Cell Adhesion Molecules; Cell Proliferation | 2015 |